Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin for vascular dementia.

P S Williams1, A Spector, M Orrell

  • 1Child & Adolescent Psychiatry, Camden & Islington CHS NHS Trust, 186a Park Road, Crouch End, London, UK, N8 8JJ. plastix@cableinet.co.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary

Aspirin is widely prescribed for vascular dementia, but evidence for its effectiveness is limited. More research is needed to determine if aspirin benefits cognition or improves prognosis in vascular dementia patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving Quality and Effectiveness in Dementia Using Crisis Teams (AQUEDUCT): a randomised controlled trial evaluating the impact of a best practice Resource Kit used by teams managing crisis in dementia.

Nature communications·2025
Same author

Results from a randomised controlled pilot study of the Better Conversations with Primary Progressive Aphasia (BCPPA) communication partner training program for people with PPA and their communication partners.

Pilot and feasibility studies·2023
Same author

Online peer support: views and experiences of people with young onset dementia (YOD).

Aging & mental health·2023
Same author

Validation of the cognitive stimulation therapy (CST) program for people with dementia in Portugal.

Aging & mental health·2020
Same author

Comparison of the adaptive implementation and evaluation of the Meeting Centers Support Program for people with dementia and their family carers in Europe; study protocol of the MEETINGDEM project.

BMC geriatrics·2017
Same author

An adapted mindfulness intervention for people with dementia in care homes: feasibility pilot study.

International journal of geriatric psychiatry·2017

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Vascular dementia patients are frequently prescribed aspirin.
  • Uncertainty exists regarding aspirin's benefits, effects on cognition, and prognosis in vascular dementia.
  • The risk of hemorrhage versus potential benefits requires evaluation.

Purpose of the Study:

  • To assess the effectiveness of aspirin in patients diagnosed with vascular dementia.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs).
  • Inclusion criteria involved RCTs assessing aspirin for vascular dementia.
  • Data extraction focused on cognitive, behavioral, mortality, morbidity, and institutionalization outcomes.

Main Results:

  • One RCT involving 70 patients met the inclusion criteria.

Related Experiment Videos

  • The study primarily assessed cognitive outcomes.
  • Results indicated a trend favoring aspirin treatment for cognitive outcomes.

    • Conclusions:

    • Limited evidence supports aspirin's effectiveness for vascular dementia.
    • Further research is necessary to evaluate aspirin's impact on cognition, behavior, and quality of life.
    • Current evidence is insufficient to address other clinical questions regarding aspirin use in vascular dementia.